Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

von Piezzo, Michela, Chiodini, Paolo, Riemma, Maria, Cocco, Stefania, Caputo, Roberta, Cianniello, Daniela, Di Gioia, Germira, Di Lauro, Vincenzo, Rella, Francesca Di, Fusco, Giuseppina, Iodice, Giovanni, Nuzzo, Francesco, Pacilio, Carmen, Pensabene, Matilde, Laurentiis, Michelino De
Veröffentlicht in Int J Mol Sci (2020)

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)

von Orditura, Michele, Gravina, Adriano, Riccardi, Ferdinando, Diana, Anna, Mocerino, Carmela, Leopaldi, Luigi, Fabozzi, Alessio, Giordano, Guido, Nettuno, Raffaele, Incoronato, Pasquale, Barzelloni, Maria Luisa, Caputo, Roberta, Pisano, Agata, Grimaldi, Giuseppe, Genua, Geppino, Montesarchio, Vincenzo, Barbato, Enrico, Iodice, Giovanni, Lieto, Eva, Procaccini, Eugenio, Mabilia, Roberto, Febbraro, Antonio, Laurentiis, Michelino De, Ciardiello, Fortunato
Veröffentlicht in ESMO Open (2017)